1 completed, 1 withdrawn. .
Follow Carcinoma of the Larynx: new trials by email Literature Review of Carcinoma of the Larynx trials Research Report on Carcinoma of the Larynx
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs Stage III Breast Cancer, Stage IV Breast Cancer | Withdrawn | Travera Inc | 2024-11-01 | 2024-11-25 | ||
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) Pleural Effusion, Malignant, Ascites, Malignant | Completed | Travera Inc | 72 | 2022-07-15 | 2026-04-13 |
Anus Neoplasms (2) · Appendiceal Neoplasms (2) · Breast Neoplasms (2) · Carcinoma (2) · Carcinoma, Hepatocellular (2) · Carcinoma, Neuroendocrine (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Cholangiocarcinoma (2) · Esophageal Neoplasms (2) · Laryngeal Neoplasms (2) · Lung Neoplasms (2) · Mesothelioma (2) · Mouth Neoplasms (2) · Neoplasms, Unknown Primary (2)
Adenocarcinoma (2) · Adenoma (2) · Adnexal Diseases (2) · Anus Diseases (2) · Breast Diseases (2) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Cecal Diseases (2) · Cecal Neoplasms (2) · Colorectal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Esophageal Diseases (2)
Travera Inc (2)
United States (1)
Mark Stevens, Ph.D. (1) · Mark Stevens, Phd (1) · Rob Kimmerling, Phd (1) · Robert Kimmerling, Ph.D. (1)